Rapport Therapeutics, Inc.-Rapport stock plunges 18% on Wednesday: what went wrong after 200% rally

Rapport stock plunges 18% on Wednesday: what went wrong after 200% rally

Rapport Therapeutics, Inc.(US:RAPP) Invezz·2025-09-10 18:22

Rapport stock (NASDAQ: RAPP) cratered 18% on Wednesday as the market delivered a harsh verdict on its latest funding strategy. The catalyst was as predictable as it was painful. ...